PharVision Advisers’s Nordic American Tanker NAT Stock Holding History

PharVision Advisers’s Portfolio NAT Stock Details NAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-30,708	Closed	-$106K	–	453
2025 Q4	$106K	Buy	+30,708	New	+$109K	0.05%	652

Other funds holding NAT

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

PharVision Advisers's NAT Position: Q1 2026 in Review

PharVision Advisers sold out of Nordic American Tanker (NAT) in Q1 2026, closing a stake of 30,708 shares — an estimated $106K sold.

PharVision Advisers first reported a position in NAT in Q4 2025 and held it in 1 quarter. The position peaked at $106K in Q4 2025. 239 funds tracked by Wall St. Rank hold NAT as of Q1 2026.

PharVision Advisers reported no remaining Nordic American Tanker position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 30,708 Nordic American Tanker shares in Q1 2026, an estimated $106K.
PharVision Advisers first reported a position in Nordic American Tanker in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Nordic American Tanker position peaked at $106K in Q4 2025.
239 funds tracked by Wall St. Rank held Nordic American Tanker as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.